Washington University in St. Louis: CRISPR Screening with ML for Precision Medicine

Neurodegenerative diseases (Alzheimer's, cancer) are without a cure partially due to our genetic differences. Using individuals' DNA, we create a library of patient-specific mutations, and through CRISPR genome editing, engineer them into live human cells.

Washington University in St. Louis: CRISPR Screening with ML for Precision Medicine
You may also be interested in:

Success with TIBCO:

Over $1 million

In projected opportunities

3 Months

Time to learn Spotfire and develop the first analysis model

Watch Webinar

To process your registration, TIBCO Software Inc. and TIBCO affiliates (collectively “TIBCO”) need to collect the below personal data from you. By registering for this TIBCO resource, you are consenting to TIBCO processing this data and contacting you by email, telephone, and/or social media with resource-related information.